New Serological Pipet Controller Features Groundbreaking Repeat Dispense Ability
By LabMedica International staff writers Posted on 27 Sep 2024 |

The conventional approach of using serological pipets for dispensing multiple aliquots is often slow, requiring constant attention to graduation marks and manual control for each dispense. Additionally, there is a continuous risk of overfilling, which can lead to filter contamination and the need for replacements. Recognizing this challenge, a revolutionary solution now promises to elevate the art of pipetting.
INTEGRA Biosciences (Zizers, Switzerland) has introduced the PIPETBOY GENIUS serological pipet controller, featuring a groundbreaking repeat dispense function. This innovation allows for faster, more accurate dispensing compared to traditional pipetting methods that rely on graduation marks. With PIPETBOY GENIUS, users can aspirate the exact total volume needed and consistently dispense aliquots ranging from 0.1 to 50 ml at the press of a button. The lightweight, compact device also offers noise- and vibration-free operation, along with advanced overfill protection to prevent liquid from being aspirated into the instrument, reducing the need to pause workflows to replace contaminated filters.
Designed to simplify lab work, the PIPETBOY GENIUS offers one-handed, intuitive control of aspiration and dispensing speeds, from slow drop-by-drop dispensing to fast rates of up to 12 ml/s. The instrument meets various experimental needs and comes with a Steady-Grip feature in its sterile module (nose piece), ensuring secure handling of serological pipets from 1 to 100 ml for enhanced stability and reliability. To add a touch of color, the PIPETBOY GENIUS is available in a variety of colors, making it both functional and visually appealing in the lab.
The PIPETBOY GENIUS allows seamless switching between manual and repeat dispense modes when used with INTEGRA serological pipets. The repeat dispense mode is ideal for fast, reproducible aliquoting, eliminating the need to manually track graduation marks on the pipet. Using this function is simple: set the dispense volume with the volume wheel, aspirate to the required level or until the overfill protection stops the flow, then press the repeat dispense button to deliver the correct volume with each aliquot. Additionally, this function eliminates the need to pipet at eye level, helping users maintain comfortable postures and reducing the risk of repetitive strain injuries.
Overfilling is a common concern in labs, as it can lead to filter contamination and the need for maintenance. The PIPETBOY GENIUS addresses this with its built-in overfill protection, especially when paired with INTEGRA serological pipets. This feature safeguards against the over-aspiration of liquids, preventing potential damage to the instrument and ensuring a streamlined workflow, giving researchers confidence in their results. Maximizing productivity is essential for lab success, and PIPETBOY GENIUS offers noise- and vibration-free pipetting with precise speed control, making it ideal for a wide range of applications, including sensitive cell handling and layering. Users can easily adjust the maximum dispense speed using a 3-position slider and fine-tune the pipetting speed with finger pressure on the aspirate and dispense buttons.
The PIPETBOY GENIUS also includes an enhanced sterile module (nose piece) featuring the Steady-Grip system, allowing for a simple click-in attachment that securely fits pipets of any volume from 1 to 100 ml, ensuring stability during use. For convenient storage, the pipet controller comes with a mounting crown that fits into a wall mount, while a ledge on the device’s top allows for upside-down storage. Another ledge at the bottom enables elevated storage with a serological pipet inserted.
Related Links:
INTEGRA Biosciences
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more